All 86 SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Holdings
There are 86 SBIO holdings. Top 10 companies weight: 34.49%.
Total Market Cap: $155B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (86 stocks) | +6.36% | 13.63 | 12.16 | 0.43 | +84.81% | +3.16% | 1.17 | ||||||||||
1 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 4.26% | $71.29 | $6.71B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +65.90% | $118 | +8.70% | 1.55 |
2 | ALKS | Alkermes Plc | 4.02% | $41.32 | $6.34B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 41.07 | 111.11 | 1.96 | N/A | N/A | 75 | +9.97% | $45 | +12.36% | 0.66 |
3 | CELC | Celcuity Inc | 4.01% | $91.42 | $6.48B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 77 | +84.86% | $169 | +29.16% | 1.06 |
4 | MIRM | Mirum Pharmaceuticals Inc | 3.86% | $92.17 | $5.93B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +56.40% | $144 | +40.23% | 0.90 |
5 | SYRE | Spyre Therapeutics Inc | 3.74% | $69.16 | $5.72B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +37.65% | $95 | -16.21% | 1.74 |
6 | CGON | Cg Oncology Inc | 3.38% | $55.53 | $5.35B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +62.60% | $90 | 0.00% | 1.46 |
7 | APGE | Apogee Therapeutics Inc | 3.00% | $78.71 | $5.82B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +50.51% | $118 | 0.00% | 1.30 |
8 | XENE | Xenon Pharmaceuticals Inc | 2.90% | $52.30 | $5.21B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +51.63% | $79 | +23.02% | 0.95 |
9 | NAMS | Newamsterdam Pharma Co Nv | 2.68% | $31.71 | $4.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +58.25% | $50 | 0.00% | 1.00 |
10 | TVTX | Travere Therapeutics Inc Ordinary Shares | 2.64% | $42.96 | $4.41B | Biotechnology | Healthcare | -44.12% | N/A | 61.73 | N/A | N/A | N/A | 76 | +26.02% | $54 | +24.56% | 1.30 |
11 | CRNX | Crinetics Pharmaceuticals Inc | 2.49% | $32.61 | $3.87B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +13.39% | N/A |
12 | DNTH | Dianthus Therapeutics Inc | 2.49% | $81.57 | $4.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
13 | ACAD | Acadia Pharmaceuticals Inc | 2.34% | $20.89 | $3.63B | Biotechnology | Healthcare | N/A | 9.59 | 62.50 | 0.16 | N/A | N/A | 72 | +51.51% | $32 | -2.17% | 0.95 |
14 | EWTX | Edgewise Therapeutics Inc | 2.33% | $37.25 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +18.58% | $44 | +7.36% | 1.37 |
15 | VKTX | Viking Therapeutics Inc | 2.30% | $29.29 | $3.67B | Biotechnology | Healthcare | +47.58% | N/A | N/A | N/A | N/A | N/A | 78 | +216.08% | $93 | +40.92% | 1.57 |
16 | DNLI | Denali Therapeutics Inc | 1.99% | $19.35 | $3.21B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +75.35% | $34 | -21.40% | 1.56 |
17 | ORKA | Oruka Therapeutics Inc | 1.85% | $55.23 | $2.91B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +157.41% | $142 | +15.52% | N/A |
18 | GPCR | Structure Therapeutics Inc Adr | 1.81% | $37.19 | $2.81B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +186.29% | $106 | 0.00% | 0.89 |
19 | TARS | N/A | 1.68% | $57.41 | $2.58B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +63.93% | $94 | +11.68% | 0.65 |
20 | IRON | Disc Medicine Inc Ordinary Shares | 1.68% | $68 | $2.66B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +48.66% | $101 | -11.63% | 1.16 |
21 | IDYA | Ideaya Biosciences Inc | 1.67% | $27.87 | $2.57B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +85.47% | $52 | +6.44% | 1.11 |
22 | RLAY | Relay Therapeutics Inc Ordinary Shares | 1.64% | $15.70 | $2.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +54.46% | $24 | -13.31% | 1.84 |
23 | VERA | Vera Therapeutics Inc Class A | 1.58% | $31.26 | $2.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +149.52% | $78 | +16.05% | 1.25 |
24 | MLYS | Mineralys Therapeutics Inc | 1.53% | $28.85 | $2.47B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +68.11% | $49 | 0.00% | 0.78 |
25 | CLDX | Celldex Therapeutics Inc | 1.33% | $28.90 | $2.11B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +102.18% | $58 | +0.58% | 1.16 |
26 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 1.33% | $17.15 | $2.08B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.97% | $34 | -37.25% | 0.90 |
27 | SION | Sionna Therapeutics Inc | 1.25% | $36.48 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +41.45% | $52 | 0.00% | 0.93 |
28 | PHVS | Pharvaris Nv Ordinary Shares | 1.24% | $28.98 | $1.92B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +60.80% | $47 | +7.21% | 0.71 |
29 | RAPP | Rapport Therapeutics Inc | 1.23% | $34.90 | $1.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +63.61% | $57 | 0.00% | 1.35 |
30 | LKFT | Lakefront Biotherapeutics Nv Adr | 1.18% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | TYRA | Tyra Biosciences Inc | 1.17% | $28.66 | $1.97B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +78.47% | $51 | 0.00% | 1.05 |
32 | VCEL | Vericel Corp | 1.15% | $34.45 | $1.75B | Biotechnology | Healthcare | +35.66% | 80.63 | 68.97 | 0.14 | N/A | N/A | 71 | +60.90% | $55 | -8.84% | 1.19 |
33 | STOK | Stoke Therapeutics Inc | 1.15% | $28.68 | $1.96B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +57.25% | $45 | -5.78% | 1.09 |
34 | SRPT | Sarepta Therapeutics Inc | 1.13% | $16.25 | $1.76B | Biotechnology | Healthcare | N/A | 4.62 | 5.73 | 159.25 | N/A | N/A | 51 | +35.38% | $22 | -26.11% | 1.39 |
35 | OCS | Oculis Holding Ag | 1.11% | $12.29 | $1.74B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +227.75% | $40 | 0.00% | 0.61 |
36 | NVAX | Novavax Inc | 1.10% | $10.21 | $1.82B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +38.20% | $14 | -43.27% | 1.50 |
37 | AGIO | Agios Pharmaceuticals Inc | 1.07% | $26.51 | $1.70B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +54.21% | $41 | -14.24% | 1.09 |
38 | NUVB | N/A | 1.05% | $4.90 | $1.64B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +151.63% | $12 | -18.26% | 1.49 |
39 | PVLA | Palvella Therapeutics Inc | 1.04% | $104.67 | $1.66B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +119.32% | $230 | 0.00% | 1.01 |
40 | TSHA | N/A | 0.99% | $5.69 | $1.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +114.94% | $12 | -23.73% | 1.40 |
41 | AMLX | Amylyx Pharmaceuticals Inc | 0.98% | $13.29 | $1.56B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +76.07% | $23 | 0.00% | 1.15 |
42 | IMTX | Immatics Nv Ordinary Shares | 0.97% | $10.04 | $1.53B | Biotechnology | Healthcare | -14.98% | N/A | N/A | N/A | N/A | N/A | 75 | +86.95% | $19 | -2.98% | 1.31 |
43 | IMCR | Immunocore Holdings Plc Adr | 0.96% | $29.56 | $1.45B | Biotechnology | Healthcare | N/A | N/A | 196.08 | N/A | N/A | N/A | 70 | +114.78% | $63 | -6.08% | 0.72 |
44 | MBX | Mbx Biosciences Inc | 0.92% | $30.70 | $1.52B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +125.05% | $69 | 0.00% | 1.46 |
45 | BCAX | Bicara Therapeutics Inc | 0.90% | $19.64 | $1.41B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +60.18% | $31 | 0.00% | 1.44 |
46 | KALV | Kalvista Pharmaceuticals Inc | 0.88% | $26.94 | $1.37B | Biotechnology | Healthcare | +11.29% | N/A | 25.45 | N/A | N/A | N/A | 60 | +6.16% | $29 | +0.41% | 0.87 |
47 | MLTX | Moonlake Immunotherapeutics Class A | 0.84% | $17.87 | $1.31B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 67 | +54.56% | $28 | +12.31% | 0.96 |
48 | MAZE | Maze Therapeutics Inc | 0.82% | $24.29 | $1.30B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +157.51% | $63 | 0.00% | 0.89 |
49 | AVBP | Arrivent Biopharma Inc | 0.80% | $29.92 | $1.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +40.71% | $42 | 0.00% | 0.94 |
50 | MNKD | Mannkind Corp | 0.70% | $3.43 | $1.10B | Biotechnology | Healthcare | -21.18% | N/A | 37.31 | 4.39 | N/A | N/A | 71 | +121.28% | $7.59 | -2.03% | 0.72 |
SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Sector Allocation
HEALTHCARE
88.60%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%